Source link : https://newshealth.biz/health-news/popular-oral-drug-for-diabetes-may-hold-intriguing-side-benefit/
(MedPage Today) — Type 2 diabetes patients starting on SGLT2 inhibitors had a sightly lower risk of autoimmune rheumatic diseases compared with those initiating sulfonylureas, a large retrospective Korean study found. Over a median follow-up… Source link : https://www.medpagetoday.com/rheumatology/generalrheumatology/117970 Author : Publish date : 2025-10-15 22:30:00 Copyright for syndicated content belongs to the linked Source.
The post Popular Oral Drug for Diabetes May Hold ‘Intriguing’ Side Benefit first appeared on News Health.
—-
Author : News Health
Publish date : 2025-10-15 22:30:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8